RecruitingPhase 2NCT07646613
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
Sponsor: Aspeya, Inc.
Roslindale, MA · Westborough, MA · +18 more sites